Editorial: New molecular approaches to improve gynecological cancer management

• Miguel Henriques Abreu,
• Miguel Henriques Abreu,
• Gabriella Lillsunde-Larsson,
• Gabriella Lillsunde-Larsson,
• Carla Bartosch,
• Carla Bartosch,
• Carla Bartosch,
• Sara Ricardo,
• Sara Ricardo,
• Sara Ricardo

Affiliations

Miguel Henriques Abreu

Department of Medical Oncology, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal

Miguel Henriques Abreu

Porto Comprehensive Cancer Center Raquel Seruca (PCCC), Porto, Portugal

Gabriella Lillsunde-Larsson

Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

Gabriella Lillsunde-Larsson

School of Health Sciences, Örebro University, Örebro, Sweden

Carla Bartosch

Porto Comprehensive Cancer Center Raquel Seruca (PCCC), Porto, Portugal

Carla Bartosch

Department of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal

Carla Bartosch

Cancer Biology & Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (CI-IPO-Porto)/Health Research Network (RISE@CI-IPO-Porto), Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal

Sara Ricardo

Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto, Porto, Portugal

Sara Ricardo

1H-TOXRUN – One Health Toxicology Research Unit, University Institute of Health Sciences (IUCS), CESPU, CRL, Gandra, Portugal

Sara Ricardo

Department of Pathology, Faculty of Medicine from University of Porto (FMUP), Porto, Portugal